1241898-88-3

Basic information

• Product Name: (2-ethyl-5-fluorophenyl)(piperidin-4-yl)methanone hydrochloride
• Synonyms: (2-ethyl-5-fluorophenyl)(piperidin-4-yl)methanone hydrochloride
• CAS NO: 1241898-88-3
• Molecular Weight: 271.762
• Mol File: 1241898-88-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2-ethyl-5-fluorophenyl)(piperidin-4-yl)methanone hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (2-ethyl-5-fluorophenyl)(piperidin-4-yl)methanone hydrochloride(1241898-88-3)
• EPA Substance Registry System: (2-ethyl-5-fluorophenyl)(piperidin-4-yl)methanone hydrochloride(1241898-88-3)

Safety Data

• Hazardous Substances Data: 1241898-88-3(Hazardous Substances Data)

Upstream product

• 261711-19-7 2-bromo-1-ethyl-4-fluorobenzene 
• 261711-20-0 1-(2-bromo-4-fluorophenyl)ethan-1-ol 
• 59142-68-6 2-bromo-4-fluorobenzaldehyde 
• 1241898-87-2 tert-butyl 4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidine-1-carboxylate 

Downstream Products

• 1241898-89-4 tert-butyl [5-(3-{4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidin-1-yl}-4,5-dihydroisoxazol-5-yl)-2H-tetrazol-2-yl]-acetate 
• 1241898-90-7 tert-butyl [5-(3-{4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidin-1-yl}isoxazol-5-yl)-2H-tetrazol-2-yl]acetate 
• 1241896-62-7 [5-(3-{4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidin-1-yl}isoxazol-5-yl)-2H-tetrazol-2-yl]acetic acid 

Relevant articles and documents

HETEROCYCLIC DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Heterocyclic compounds of structural formula (I), or a pharmaceutically acceptable salt thereof, wherein W is a R1— substituted heteroaryl, R1 is an heteroaryl ring substituted with an ester or carboxylic acid containing radical, X-T is N—CR5R6, C═CR5 or CR13—CR5R6, Y is a bond or —C(O)—, a and b represent an integer selected from 1 to 4, and Ar is an optionally substituted phenyl or naphtyl, are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD) The heterocyclic compounds are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, atherosclerosis, obesity, diabetes, neurological disease, Metabolic Syndrome, insulin resistance, cancer, liver steatosis, and non-alcoholic steatohepatitis.